FDA Warning Letter Response

The situation

Natalie runs a 9-person dietary supplement company in Austin, Texas, she sells a line of herbal immune support products through Amazon and her own website. Last week, she received an FDA Warning Letter citing three violations: (1) her product page describes her elderberry supplement as "prevents viral infections", an unapproved drug claim that transforms her supplement into an unlicensed drug; (2) her company's facility lacks a written FSMA Food Safety Plan required under 21 CFR Part 117; (3) she has 15 business days to respond in writing. Natalie doesn't know: (a) the "prevents viral infections" claim must be immediately removed from ALL marketing channels (Amazon, her website, social media, email campaigns, physical labels), the response must document that the removal has already happened; (b) the disease claim violation is the most serious citation type and creates personal liability exposure for company officers in addition to corporate liability; (c) the FSMA Food Safety Plan failure requires a written corrective action plan with a specific timeline for plan development and implementation, she needs to commit to a realistic timeline (not "we will comply immediately" if she can't actually do it that fast); (d) FDA's standard for an "adequate" response requires all four components: acknowledge the violation, state what's already been corrected, state what's being corrected with dates, state what will prevent recurrence, missing any component makes the response "inadequate"; (e) a regulatory compliance consultant quoted her $18,000 for the full Warning Letter response package. Her Amazon listing drives 60% of her revenue and she can't afford to have it suspended.

Who receives this

Small food manufacturers (10-100 employees), dietary supplement companies, nutraceutical brands, and cosmetics companies that received an FDA Warning Letter. Primary: companies that received Warning Letters for disease claims in supplement marketing or FSMA violations, the two most common small-company Warning Letter categories. Secondary: companies that received cGMP deficiency Warning Letters after a facility inspection, and importers who received Warning Letters that may trigger an import alert if not adequately addressed.

Why the agency will not advise you

The FDA issues Warning Letters and enforces compliance, it cannot build "how to respond to our Warning Letters" tools for regulated companies. Regulatory consulting firms (The FDA Group, FDA Consulting Group, Zamann Pharma) charge $10,000-$50,000+ per engagement and are not incentivized to provide a $149-399 self-serve alternative. Atlas Compliance AI and RegulatoryIQ.ai serve the market for ANALYZING FDA Warning Letters in the aggregate (competitive intelligence, compliance risk assessment), not for helping the specific cited company write their response. The food law firm market (The Food Law Firm) charges attorney rates. The gap: a small supplement company without regulatory affairs staff needs to understand what an "adequate" response looks like, what has to be fixed before the response is submitted, and what the 15-business-day clock means in terms of timeline pressure.

Key facts, with sources

• The FDA issues approximately 400-600 Warning Letters per year across all product categories (foods, dietary supplements, drugs, medical devices, cosmetics, tobacco). In 2025, the FDA issued ~470 Warning Letters (breakdown: drugs ~200, medical devices ~100, foods/dietary supplements ~150, other ~20). For food and dietary supplement Warning Letters, the most common citations are: (1) unapproved drug claims, marketing a dietary supplement with disease claims like 'treats cancer', 'cures diabetes', or 'prevents COVID-19' without an approved New Drug Application (the most common supplement Warning Letter type, dozens per year); (2) FSMA violations, failure to implement or maintain a written Food Safety Plan under 21 CFR Part 117 (Preventive Controls for Human Food); (3) cGMP violations, failure to maintain adequate laboratory testing records, batch records, or supplier qualification for dietary supplements under 21 CFR Part 111. The FDA requires written response within 15 business days of the Warning Letter. Source: Inside 470 FDA Warning Letters From 2025: What Labs Need to Know — qbench
• A 15-business-day response is non-negotiable, the FDA does not grant extensions for Warning Letter responses in most cases. An inadequate or late response to a Warning Letter can trigger: (1) product seizure (FDA can seek a federal court order to seize and destroy the product without further notice to the company); (2) injunction (federal court order prohibiting operations until violations are corrected); (3) import alert (for importers, all shipments of the listed product are automatically detained at the US border, economically devastating for small importers); (4) referral to the Department of Justice for criminal prosecution for serious or intentional violations. The '15 business days' deadline begins from the date on the Warning Letter, not the date of receipt. Source: About Warning and Close-Out Letters — FDA
• Small food manufacturers, dietary supplement companies, and cosmetics manufacturers are the most common Warning Letter recipients among the non-pharmaceutical FDA-regulated industries. The dietary supplement industry includes ~50,000 US companies, with the majority being small companies (1-50 employees) that lack in-house regulatory affairs staff. Regulatory consulting firms charge $10,000-$50,000+ to respond to a Warning Letter: The FDA Group (thefdagroup.com) advertises 'Warning Letter Response and Remediation Services'; FDA Consulting Group (fdacg.com) offers 'FDA Warning Letter Response Consultants'; the elexes.com list of 'Top 10 FDA Warning Letter Response Consultants in 2026' shows the market is served entirely by premium consulting. No self-serve tool exists at a price point accessible to a small supplement company or food manufacturer. Source: FDA Warning Letter Response and Remediation Services — The FDA Group

When to bring in a professional

Self-serve responses fit routine cases: clear facts, amounts a business can absorb, and a deadline still ahead of you. Bring in a licensed professional when the amount at stake is large relative to their fee, the facts are genuinely disputed, criminal exposure is possible, or the deadline has already passed. A short paid consultation to sanity-check your plan is often worth it even when you handle the filing yourself.

All sources for this guide

1. Inside 470 FDA Warning Letters From 2025: What Labs Need to Know — qbench
2. About Warning and Close-Out Letters — FDA
3. FDA Warning Letter Response and Remediation Services — The FDA Group